Statistics for Greenwich LifeSciences, (id:5532 GLSI)
Valuation metrics
Market cap
165.10M
Enterprise value
171.41M
Trailing P/E (ttm)
-19.64
Forward P/E
-15.32
PEG ratio
-15.32
Price/Sales (ttm)
Price/Book (mrq)
24.06
Enterprise Value/Revenue
Enterprise Value/EBITDA
-16.27
Overview
Shares outstanding
13.14M
Float
5.92M
Shares short
484.60K
% Held by insiders
0.53%
% Held by institutions
0.09%
Average volume (10 days)
34.33K
Average volume (90 days)
Price summary
52-Week low
8.00
52-Week high
21.44
52-Week change
11.66%
Beta
3.32
50-Day moving average
13.97
200-Day moving average
14.40
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-72.45%
Return on equity
-123.67%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-10,533,951.00
Net income to common (ttm)
-10,218,405.00
Diluted EPS (ttm)
-0.79
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
7.22M
Total cash per share (mrq)
0.55
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
534.00%
Book value per share (mrq)
0.52
Cash flow
Cash flow statement
-6,785,223.00
Levered free cash flow (LFCF)
-3,152,795.00